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Abstract: Many individuals in America suffer from chronic
diseases (Glaucoma, Cancer, PTSD, HIV/AIDS, and
multiple sclerosis) and medical marijuana can alleviate the
side effects associated with these conditions. The federal
government should legalize marijuana in order to give
individuals with chronic diseases the organic medication
they need to manage their symptoms. The current literature
discusses how this topic is a national and community
healthcare issue due to the large numbers of individuals with
chronic conditions who could benefit from access to medical
marijuana. Medical marijuana has the ability to improve the
cost, access, and quality of healthcare in the United States
for persons living with chronic diseases. This paper explores
how cannabis impacts the delivery of healthcare as well
as populations who are impacted. Additionally, this paper
explores how this topic applies to occupational science, the
future role of healthcare providers, and current healthcare
policies.
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Medical

Cannabis,

Medical marijuana is an herbal drug that has existed for thousands
of years and is used to help manage certain health issues. Historically,
cannabis dates back as far as 12,000 years and is among the oldest
cultivated crops with its roots beginning in central Asia (Warf, 2014).
Based on carbon-14 dating, the first documented use of medical marijuana
was for Chinese Emperor Shen Nung in 2737 BC as an anesthetic during
surgery (Warf, 2014). It was also used in ancient China for rope, clothing,
sails, and bowstrings. Currently, medical marijuana is illegal by the federal
government and any state allowing its use for medical purposes is breaking
federal law. Based on research and individual testimonies, marijuana ranks
high in its medicinal purposes. It benefits those suffering from Aids/HIV,
Glaucoma, multiple sclerosis, cancer, post traumatic stress syndrome, and
many more medical conditions (Thompson, 2016; Vargo, 2016). Medical
marijuana is an important potential medication because it has low sideeffects compared to other medications used to treat these conditions (Grant,
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Atkinson, & Gouaux, 2012). This article will be investigating how medical
marijuana is used today and how it affects the healthcare system.
Methods
The purpose of this research project was to find scholarly articles
related to medical marijuana to analyze this topic in relation to current
legislation, healthcare policies, and occupational science concepts, as well
to identify the populations most impacted by lack of access to medical
marijuana. The method of this project included an extensive search of the
literature through the following scholarly databases such as Academic
Search Complete, Google Scholar, and PubMed. Additionally, newspapers,
textbooks, and national magazines were also searched for relevant
information related to the topic. The following main keywords were used
in the literature search process: Medical cannabis, medical marijuana,
cancer, glaucoma, AIDS/HIV, multiple sclerosis, PTSD, Marijuana policy,
marijuana litigation, occupational marginalization.
National and Community Healthcare Issue
Medical marijuana is a national and community healthcare issue
because nationally it is classified by the federal government as a schedule
1 narcotic; thus, categorizing it as an illegal substance with no “medical
value.” Because marijuana is a Schedule 1 narcotic, its possession and sale
are subject to the most severe criminal penalties (Titus, 2016). Some states
have legalized medical marijuana, but because its use is a federal crime,
insurance companies will not cover the cost of this medication (Luthra,
2016).
Nationally, many people suffer from chronic diseases of which
marijuana can alleviate side-effects. A recent article tells the story of how
marijuana helped a US Army infantryman wean off many high side effect
medications. He was able to replace as many as 150 medications a day with
medical marijuana (Thompson, 2016). In addition, marijuana has little to
no harmful side-effects and is essentially non-addictive. Marijuana use can
not be fatal and no deaths have ever been reported from marijuana overdose
(Vargo, 2016).
As far as being a community (Kentucky) healthcare issue, marijuana
is currently illegal in this state. Kentucky also has high rates of opiate
overdose and drug abuse. Medical marijuana is a community healthcare
issue because it can be used to treat the same conditions that opiates are
“treating” without the fear of addiction or overdosing. In 2015, Kentucky
had 1,248 overdose deaths, but it is expected that the number will increase
as more reports are available for calculation (Estep, 2016). Research shows
that medical marijuana can be useful in the treatment of pain, making it a
potentially suitable alternative to opioids for some individuals (Thompson,
2016). If marijuana instead of opiates were being prescribed to individuals
https://encompass.eku.edu/kjus/vol2/iss1/4
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with chronic pain, this overdose rate would go down because one can not
overdose on marijuana. Doctors take patients off of opiates after a period
of use and this results in a potential heroin user because it is cheaper to buy
heroin on the street than it is to purchase an opiate (Narconon International,
2016).
How Marijuana Impacts the Delivery of Healthcare
Medical marijuana impacts the delivery of healthcare because it
changes and will continue to change the way pharmacists perform their job.
A recent pharmaceutical publication suggested that pharmacists need to
understand the legal framework surrounding medical marijuana so they can
protect themselves and better serve their patients (Seamon, 2007). Pharmacy
schools are already considering and planning how they will incorporate
medical marijuana into the curriculum if it becomes legalized nationally. A
study examining pharmacy student’s attitudes on marijuana explained that
if this medication becomes legal, students will need education and training
to address its safe and effective use (Moeller & Woods, 2015).
Furthermore, marijuana impacts the delivery of healthcare because
it changes and will continue to change the way doctors do their job. In
states that have legalized marijuana, doctors are already “recommending”
marijuana to their patients. “In 2002, the Ninth Circuit affirmed the grant
of an injunction barring the federal government from punishing physicians
who recommend marijuana to their patients for medical use in Conant v.
Walters” (Mccarthy, 2004, p. 333). Doctors no longer fear being punished
for recommending marijuana. However, in the states that do allow the
use of medical cannabis, doctors are not allowed to prescribe it, they can
only recommend its use (Marcoux, Larrat, & Vogenberg, 2013). Until the
federal government legalizes medical marijuana doctors will not be allowed
to formally “prescribe” it in the traditional manner needed for insurance
coverage. Currently, insurance companies do not cover medicinal marijuana.
Medical marijuana has also impacted the delivery of healthcare
by creating collaboration between physicians and marijuana dispensaries,
adding a new specialty area to doctors’ resume. Doctors are collaborating
with dispensaries and other clinicians to utilize their specialized knowledge
on the best strains of marijuana for the particular condition, safest
administration route, and lowest effective dose (Metts, Wright, Sundaram,
& Hashemi, 2016). Legalizing marijuana will impact health care providers
(doctors/pharmacist) by allowing them to legally provide at times the best
and safest care through an additional medical route.
Population Impacted and in What Ways
The population that will be impacted by the legalization of medical
marijuana will be individuals suffering with chronic diseases such as
glaucoma, cancer, HIV/AIDs, PTSD, and MS. Hospice health professionals
Published by Encompass, 2018

22

MEDICAL MARIJUANA

were assessed in a survey and approximately 90% supported legalization
of marijuana (Uritsky, McPherson, & Pradel, 2011). With large support
from Hospice, which specializes in chronic condition management, this
reflects professional support that medical marijuana can positively impact
individuals with chronic conditions.
Medical marijuana impacts individuals with glaucoma by reducing
the intraocular pressure associated with this condition (Chapkins, 2007).
The intraocular pressure is the fluid pressure inside of the eye that builds up
over time. This can cause pain and also lead to cranial nerve II (optic nerve)
damage, which can result in blindness. Cannabis also impacts individuals
with AIDS/HIV who experience appetite loss. Trials in AIDS patients with
clinically significant weight loss indicated that dronabinol significantly
outperformed a placebo in terms of appetite enhancement (Grant, Atkinson,
& Gouaux, 2012). Dronabinol is essentially tetrahydrocannabinol (pill
form), which is a byproduct derived from marijuana. In addition, a systematic
review and meta-analysis found evidence suggesting that cannabinoids like
dronabinol and others were associated with weight gain in patients with
HIV/AIDs (Metts, Wright, Sundaram, & Hashemi).
Individuals with cancer are also highly impacted by medical
marijuana. Marijuana is known to stimulate appetite, making its use in
reducing che¬motherapy-associated nausea and vomiting wide¬ spread.
(Vargo, 2016). Medical cannabis also alleviates the chronic pain associated
with chemotherapy and helps prevent chemo induced anorexia associated
with the loss of appetite. Despite the variation in state laws regard¬ing
the conditions approved to use medical marijuana, cancer is included as
a qualifying illness in every state that allows it (Vargo, 2016). Essentially,
marijuana is commonly believed to alleviate the side-effects associated with
cancer, given its access in all states that have it legalized.
Marijuana also impacts individuals with PTSD. A recent study
showed that patients who smoked cannabis saw a 75 percent reduction in
PTSD symptoms (“State Approves PTSD for Medical Marijuana”, 2016).
According to the Veterans Administration, nearly 30 percent of veterans who
served in the Iraq and Afghanistan wars suffer from PTSD (State Approves
PTSD for Medical Marijuana, 2016). The federal government estimates that
500,000 of the 2.7 million troops who served in those wars may have the
condition (Thompson, 2016). Marijuana reduces PTSD symptoms such as
but not limited to anxiety, flashbacks, and depression (Thompson, 2016).
Medicinal marijuana has strong potential to make a positive impact on the
lives of those suffering from PTSD.
Cannabis also impacts individuals with multiple sclerosis by
relieving chronic neuropathic pain and spasticity (Vargo, 2016). In addition
to this, “a 2015 systematic review and meta-analysis found moderate quality
evidence to support its use for the treatment of chronic and neuropathic
pain and spasticity associated with multiple sclerosis” (Metts, 2016, p. 78).
Essentially, multiple sclerosis is a progressive disease that damages the
myelin sheaths in the brain and spinal chord that can cause symptoms such
https://encompass.eku.edu/kjus/vol2/iss1/4

23

Kentucky Journal of Undergraduate Scholarship, Issue 2, (2018)

as numbness, impaired muscular coordination and fatigue. Marijuana can
have a large impact on individuals with MS by alleviating the neuropathic
pain and spasticity associated with the disease.
Chronic pain affects more Americans than diabetes, heart disease,
and cancer combined with over 100 million people living with chronic pain
(American Academy of Pain Medicine, 2017). Due to the nature of chronic
pain, a significant portion of this population likely has reduced occupational
performance, meaning they struggle to perform the required activities, tasks,
and roles of everyday living. Given the amount of individuals impacted
from pain such as those with cancer, MS, and Glaucoma, medical marijuana
has a role in chronic pain management. Essentially, cannabis can enhance
occupational performance in individuals who experience chronic pain
by alleviating their discomfort and allowing them to perform without the
burden of pain to achieve greater functional levels.
Many individuals in America suffer from chronic diseases
(Glaucoma, Cancer, PTSD, HIV/AIDS, and multiple sclerosis) and medical
marijuana can alleviate the side effects associated with these conditions. The
federal government should legalize marijuana in order to give individuals
with chronic diseases the organic medication they need to manage their
symptoms.
Medical Marijuana and Healthcare Principles
The healthcare delivery system and medical marijuana are related
through the discussion of: cost, access, and quality (Shi & Singh, 2015).
Legalizing medical marijuana could improve those three aspects of
healthcare. Medical marijuana is cost effective. For example, giving an HIV/
AIDS patient a prescription for medical marijuana to increase their appetite
and reduce their nausea, vomiting, and pain would be more cost effective
than prescribing three different medications that one medication (medical
marijuana) can treat. Medical marijuana price varies from state to state.
Although, Denver dispensaries charge medicinal customers around $10 per
gram (Ross, 2014). It is difficult to compare other individual drug prices
to medical marijuana, as many publically available drug prices provided
online are listed at the insurance discounted rate. This same scenario and
condition can be applied to the quality aspect of healthcare. For example,
the AIDS/HIV patient is receiving an unjust quality of care by being placed
on opiates for pain. They are being put at unnecessary risk for addiction and
liver damage, among other risk. In relation to access, there is no safe access
because the federal government can step in at any time at the state level to
convict a medical marijuana user even in a state where it is legalized. Also,
not all states have legalized marijuana.
How Medical Marijuana Applies to Occupational Science
Medical marijuana applies to occupational science because the
Published by Encompass, 2018
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federal government not allowing individuals to use this medication is
occupational marginalization. Occupational marginalization occurs when
individuals are oppressed by a higher power, such as the government, from
making decisions and choices regarding their occupational participation
(Christiansen & Townsend). Essentially, persons with chronic conditions
and other illnesses are marginalized and have no autonomy in the occupation
of using medical marijuana to reduce their symptoms to support function.
The government creates restrictions, policies, and laws that prevent
individuals with chronic diseases from fully engaging in health maintenance
as an occupation, even with a doctor’s recommendation. Individuals also
experience barriers in the occupation of growing marijuana, which could
be experienced as a relaxing occupation to promote restoration while
living with a debilitating and stressful disease. Clients may not be able to
complete other valued occupations, such as work and leisure task, because
the symptoms associated with their condition are not alleviated due to lack
of access.
Kielhofner (2008) describes volition as “pattern of thoughts and
feelings about one-self as an actor in one’s world which occur as one
anticipates, chooses, experiences, and interprets what one does” (p. 47). How
one takes care of oneself, decides their health treatment plan, and lives their
life are aspects of one’s volition. Many individuals with chronic conditions
value and have interest in medical marijuana because it is an organic and low
side-effect treatment option for their condition. Having more options and
autonomy related to medications for symptom management would increase
a client’s volition by giving them choice in their treatment to support their
health.
Application as A Future Healthcare Provider
Medical marijuana applies to the future role as a healthcare provider
because one could potentially encounter a patient prescribed medical
marijuana. This topic is important because as a future health care provider,
it is one’s responsibility to ensure that the patient gets the best quality of
therapy out of every session. Therefore, if a client is suffering from chronic
pain, the provider could advise nursing to administer their medical marijuana
30 minutes before the therapist arrives to ensure the client is not suffering
from pain during the therapy session. This is a common practice in acute
care therapy, in which the nurse will give patients pain medication before
rehabilitation staff provide care to the individual. As a healthcare provider,
it is also one’s responsibility to counsel the patient about safety. If an OT
is providing an intervention to a patient to help them establish a weekly
medication routine, they could read the pharmacist’s recommendations and
medication side-effects and make a sign in the medicine cabinet to remind
the patient about contraindications. The therapist could also be an advocate
for the patient by attending local and national legislative events to promote
the medical benefits of marijuana.
https://encompass.eku.edu/kjus/vol2/iss1/4
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Occupational therapists are seeing more patients with chronic pain
in their daily practice. OTs need to stay informed of the techniques doctors
are using with patients to alleviate pain, including prescription marijuana
(Karplus, 2014). As a future healthcare provider, it is one’s responsibility
to stay current on medications that patients are taking, including medical
marijuana. Occupational therapy practitioner’s have a direct role in
chronic pain management. They help identify, teach, implement, facilitate,
collaborate, and recommend chronic pain management strategies to clients
(AOTA, 2016). This is why it is paramount that OTs be informed about
medical marijuana.
Relevance of Medical Marijuana to Current Healthcare Policies
Medical marijuana is relevant to current healthcare policies because
it is a healthcare policy movement that has been gaining a large amount of
attention in the United States. Nationally, federal laws prohibit medical and
recreational marijuana. At the state level, it is only legal in 26 states. All
states that have medical marijuana have approved it for cancer care (Vargo,
2016). This is the only condition in which all states allow a mutual access to
medical marijuana. States vary on the approval for other conditions such as
AIDS/HIV, glaucoma, MS, and PTSD. However, the policies in most states
allow all of these.
Medical marijuana is a schedule 1 narcotic, which is why it is illegal.
Doctors are allowed to “recommend” it without prosecution; however,
insurance companies do not cover medical marijuana. Recently, “the DEA
approved the first-ever study of the use of the marijuana plant itself, not
individual extracts, as a therapeutic drug” (Thompson, 2016, p. 36). This
could shift current healthcare policies because if the DEA made marijuana a
schedule 2 drug, this would put it in the category of drugs such as morphine
and oxycodone. This would make it easier for doctors to prescribe and
more likely that insurance companies would cover this medication (Luthra,
2016). This would make medical marijuana accessible to individuals with
chronic conditions.
Implications and Consequences on Healthcare Service Delivery
The federal government should drop marijuana from a schedule 1
narcotic to a schedule 2 narcotic so doctors can formally prescribe it instead
of only recommending it. This process would have to be completed through
legislation. Following the legalization from the federal government,
insurance companies would begin to cover medical marijuana because
it would be in the same category as morphine and oxycodone, which are
covered by insurance companies (Luthra, 2016). One major consequence of
legalizing medical marijuana is that doctors and pharmacists would have to
be trained on this drug. In the beginning of legalization, the novelty of this
medication could cause over or under prescription. Necessary education
Published by Encompass, 2018
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on dosage, strands, and ingestion routes could be incorporated into
pharmacy schools and medical schools during academic preparation. For
professionals who are already practicing, they could obtain this education
through continuing education units. Medical marijuana would also affect big
pharmaceutical companies by decreasing the amount of other drugs being
prescribed because marijuana has such as wide scope of practice, which
could lower pharmaceutical company profits. In states that have already
legalized medical marijuana, research showed a decline in the number of
Medicare prescriptions for chronic pain, anxiety and depression. They
also saw reductions in Medicare part D spending, which covers the cost of
prescription medications (Luthra, 2016). Legalizing medical marijuana has
the potential to decrease healthcare spending, while also reducing symptoms
to improve quality of life and increase function.
Conclusion
Medical marijuana is a schedule 1 narcotic; therefore, it is federally
illegal, but is legal in some geographic areas at the state level. This drug has
the potential to reduce the opiate problem in Kentucky. Medical marijuana can
impact the delivery of healthcare because it will change the way healthcare
providers perform their jobs, specifically physicians and pharmacists.
Medical marijuana can be beneficial for persons with cancer, HIV/AIDS,
MS, PTSD, and glaucoma as well as having the potential to improve cost,
access, and quality of healthcare for these individuals. Medical marijuana
is a drug that healthcare providers may need to become familiar with in the
future as practicing clinicians. Medical cannabis is relevant to healthcare
because it is already legal in 26 states and may eventually become legalized
nationally. Marijuana should be reduced from a schedule 1 narcotic to a
schedule 2 for federal legalization. Access to medical marijuana can reduce
symptoms and improve quality of life for individuals with a variety of
conditions
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